Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray analysis of thioacetamide-treated type 1 diabetic rats.

Sachin S Devi1, Harihara M Mehendale

  • 1Department of Toxicology, College of Pharmacy, The University of Louisiana at Monroe, 700 University Ave, Sugar Hall # 306, Monroe, LA 71209-0470, USA.

Toxicology and Applied Pharmacology
|November 22, 2005
PubMed
Summary

Diabetes increases liver injury sensitivity. Thioacetamide (TA) in diabetic rats impairs tissue repair by altering protease and cell division gene expression, leading to liver damage progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wnt/β-Catenin Signaling Drives Thioacetamide-Mediated Heteroprotection Against Acetaminophen-Induced Lethal Liver Injury.

Dose-response : a publication of International Hormesis Society·2017
Same author

Hepatic Overexpression of Annexin A1 and A2 in Thioacetamide-Primed Mice Protects Them Against Acetaminophen-Induced Liver Failure and Death.

International journal of toxicology·2016
Same author

Measuring covalent binding in hepatotoxicity.

Current protocols in toxicology·2012
Same author

Once initiated, how does toxic tissue injury expand?

Trends in pharmacological sciences·2012
Same author

Dose-dependent liver tissue repair in chloroform plus thioacetamide acute hepatotoxicity.

Environmental toxicology and pharmacology·2011
Same author

Liver regeneration: a critical toxicodynamic response in predictive toxicology.

Environmental toxicology and pharmacology·2011

Area of Science:

  • Hepatology
  • Molecular Biology
  • Diabetology

Background:

  • Diabetes mellitus significantly heightens susceptibility to hepatotoxic agents.
  • Previous research demonstrated that a high dose of thioacetamide (TA) is lethal to type 1 diabetic rats due to impaired liver tissue repair.
  • Lower TA doses in diabetic rats result in delayed tissue repair and recovery.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind impaired tissue repair and liver injury progression in thioacetamide-treated diabetic rats.
  • To investigate the role of gene expression changes in thioacetamide-induced liver damage in diabetic models.

Main Methods:

  • Utilized cDNA microarray to analyze gene expression patterns at 0, 6, and 12 hours post-thioacetamide challenge.
  • Confirmed microarray findings using real-time RT-PCR.

Related Experiment Videos

  • Investigated protein level changes over a 0 to 36-hour time course.

    • Main Results:

    • Diabetic rats exhibited elevated protease and reduced protease inhibitor gene expression, exacerbated by thioacetamide administration.
    • High-dose thioacetamide (300 mg/kg) in diabetic rats suppressed cell division cycle genes (e.g., cyclin D1, E2F), inhibiting tissue repair.
    • Low-dose thioacetamide (30 mg/kg) caused delayed expression of cell division genes, leading to delayed repair.

    Conclusions:

    • Impaired cyclin D1 signaling, coupled with an imbalance of proteases and protease inhibitors, contributes to compromised tissue repair in diabetic rats.
    • These molecular alterations explain the progression of thioacetamide-induced liver injury in diabetic models.